Aller au contenu principal
RestrictedOfficial guidanceCAOriginal is EnglishImport de la source officielle contrôlé

Azelaic acid and its salts

Canada Hotlist: Azelaic acid and its salts

Health Canada lists this ingredient as restricted; the listed conditions and warnings apply.

Décision réglementaire et conditions complètes

Statut
Restricted
Rôle juridique
Official guidance
Résumé réglementaire
Health Canada lists this ingredient as restricted; the listed conditions and warnings apply.
Conditions et restrictions

Synonyms or related compounds: Nonanedioic acid; Disodium Azelate; Dipotassium Azelate · Maximum concentration: 14%

Identité de la substance

Nom dans la source officielle
Azelaic acid and its salts
CAS
123-99-9; 52457-54-2; 132499-85-5; 17265-13-3; 27825-99-6
EC
Not supplied in this source row
Correspondance d’identité
Exact CAS: 123-99-9
Ingrédient associé
AZELAIC ACID

Données d’identité CosIng associées

Noms et alias

AZELAIC ACID

Description CosIng : Nonanedioic acid

Fonction cosmétique enregistrée : BUFFERING, FRAGRANCE

Pages de fonctions :BUFFERING, FRAGRANCE

Voir le profil complet de l’ingrédient

Aperçu multi-marchés pour cette identité

Fiches exactes associées actuellement présentes sur ce site. L’absence d’un marché signifie qu’aucune correspondance exacte n’a été importée, et non une autorisation d’utiliser la substance.

4 jeux de données de marchés
Structure chimique 2D PubChem pour le CAS 123-99-9
CAS 123-99-9PubChem CID 2266

Chimie vérifiée pour le CAS 123-99-9

Azelaic Acid

Nonanedioic acid is an alpha,-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. It has a role as an antibacterial agent, an antineoplastic agent, a dermatologic drug and a plant metabolite. It is a dicarboxylic fatty acid and an alpha,omega-dicarboxylic acid. It is a conjugate acid of an azelaate and an azelaate(2-). — ChEBI

Nom IUPAC
nonanedioic acid
Formule moléculaire
C9H16O4
Masse moléculaire
188.22 g/mol
Masse exacte
188.10485899 Da
Masse monoisotopique
188.10485899 Da
XLogP3
1,6
Surface polaire topologique
74,6 Ų
Complexité moléculaire
147,0
Charge formelle
0
Donneurs de liaisons hydrogène
2
Accepteurs de liaisons hydrogène
4
Liaisons rotatives
8
Atomes lourds
13
Unités covalentes
1

Noms et synonymes signalés à PubChem

FinaceaAnchoic acidLepargylic acid1,7-Heptanedicarboxylic acidAzelexSkinorenHeptanedicarboxylic acidEmerox 1110
16 autres noms signalés
1,9-Nonanedioic acidEmerox 1144n-Nonanedioic acidAcido azelaicoacide azelaiqueacidum azelaicumAzelaic acid, technical grade1,7-DicarboxyheptaneZK 62498ZK-62498Finacea FoamF2VW3D43YTNSC-19493CHEBI:481314-02-00-02055 (Beilstein Handbook Reference)hydron;nonanedioate
Identifiants de bases de données externes
Statistiques de structure avancées
Stéréocentres atomiques définis
0
Stéréocentres atomiques non définis
0
Stéréocentres de liaison définis
0
Stéréocentres de liaison non définis
0
Caractéristiques pharmacophoriques 3D
6
Cycles 3D
0
Groupes hydrophobes 3D
0
Caractéristiques d’accepteur 3D
4
Caractéristiques de donneur 3D
0
Centres anioniques 3D
2
Centres cationiques 3D
0
Conformères 3D
10
Rotors 3D effectifs
8,0
Identifiants de structure lisibles par machine
SMILES
C(CCCC(=O)O)CCCC(=O)O
InChI
InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)
InChIKey
BDJRBEYXGGNYIS-UHFFFAOYSA-N

Preuves issues de bases de données scientifiques complémentaires

NIH PubChem PUG-View
Correspondance exacte d’identifiant2266

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 6.5% (71 of 1087) of reports. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (40.2%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (93.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1087 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 71 of 1087 reports by companies.; There are 11 notifications provided by 1016 of 1087 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org Source: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: The exact mechanism of action of azelaic acid is not known. It is thought that azelaic acid manifests its antibacterial effects by inhibiting the synthesis of cellular protein in anaerobic and aerobic bacteria, especially Staphylococcus epidermidis and Propionibacterium acnes. In aerobic bacteria, azelaic acid reversibly inhibits several oxidoreductive enzymes including tyrosinase, mitochondrial enzymes of the respiratory chain, thioredoxin reductase, 5-alpha-reductase, and DNA polymerases. In anaerobic bacteria, azelaic acid impedes glycolysis. Along with these actions, azelaic acid also improves acne vulgaris by normalizing the keratin process and decreasing microcomedo formation. Azelaic acid may be effective against both inflamed and noninflamed lesions. Specifically, azelaic acid reduces the thickness of the stratum corneum, shrinks keratohyalin granules by reducing the amount and distribution of filaggrin (a component of keratohyalin) in epidermal layers, and lowers the number of keratohyalin granules. Source: Toxin and Toxin Target Database (T3DB)
  • Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for 1,7-heptanecarboxylic acid(SRC), using a log Kow of 1.57(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to have moderate mobility in soil(SRC). The pKa of 1,7-heptanecarboxylic acid is 4.55(4), indicating that this compound will exist almost entirely in the anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization from moist soil is not expected because the acid exists as an anion and anions do not volatilize. 1,7-Heptanecarboxylic acid is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 1.07X10-8 mm Hg(6). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(7). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to adsorb to suspended solids and sediment(SRC). A pKa of 4.55(4) indicates 1,7-heptanecarboxylic acid will exist almost entirely in the anion form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process(5). According to a classification scheme(6), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(8). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 1,7-heptanecarboxylic acid, which has a vapor pressure of 1.07X10-8 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase 1,7-heptanecarboxylic acid is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 40 hrs(SRC), calculated from its rate constant of 9.8X10-12 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase 1,7-heptanecarboxylic acid may be removed from the air by wet or dry deposition(SRC). 1,7-Heptanecarboxylic acid does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Industry Uses: Monomers; Lubricating agent; Wetting agent (non-aqueous); Binder; Intermediate; Not Known or Reasonably Ascertainable; Corrosion inhibitor; Plasticizer Source: EPA Chemical Data Reporting (CDR)
  • Cosmetic Ingredient Review Link: CIR ingredient: Azelaic Acid Source: Cosmetic Ingredient Review (CIR)
  • Sources/Uses: Found in rancid oleic acid; [Merck Index] Used in organic syntheses, lacquers, alkyd resins, low-temperature plasticizers, adhesives, polyamides, urethane elastomers, and for the treatment of acne; [HSDB] Natural component of foods such as whole grain cereals and animal products; [REPROTOX] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Industrial Processes with risk of exposure: Painting (Pigments, Binders, and Biocides) [Category: Paint]; Working with Glues and Adhesives [Category: Other]; Plastic Composites Manufacturing [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Azelaic acid is used in lacquers, alkyd resins, plasticizers, adhesives, polyamides, urethane elastomers, and organic syntheses. Azelaic acid is also used in treating of acne. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Organic synthesis, lacquers, product of hydrotropic salts, alkyd resins, polyamides, polyester adhesives, low-temperature plasticizers, urethane elastomers Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Use (kg; approx.) in Germany (2009): >1000; Consumption (g per capita; approx.) in Germany (2009): 0.0122; Calculated removal (%): 92.2 Source: NORMAN Suspect List Exchange
  • Uses: For the topical treatment of mild-to-moderate inflammatory acne vulgaris. Source: Toxin and Toxin Target Database (T3DB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Structure chimique 2D PubChem pour le CAS 132499-85-5
CAS 132499-85-5CAS 17265-13-3PubChem CID 159815

Chimie vérifiée pour le CAS 132499-85-5

Azelaic acid, disodium salt

Nom IUPAC
disodium;nonanedioate
Formule moléculaire
C9H14Na2O4
Masse moléculaire
232.18 g/mol
Masse exacte
232.06874749 Da
Masse monoisotopique
232.06874749 Da
Surface polaire topologique
80,3 Ų
Complexité moléculaire
136,0
Charge formelle
0
Donneurs de liaisons hydrogène
0
Accepteurs de liaisons hydrogène
4
Liaisons rotatives
6
Atomes lourds
15
Unités covalentes
3

Noms et synonymes signalés à PubChem

RefChem:135012Disodium azelateNonanedioic acid, disodium saltdisodium nonanedioateNonanedioic acid, sodium salt (1:2)0P4H8NH3UJUNII-0P4H8NH3UJsodium azelate
3 autres noms signalés
EINECS 241-298-4SODIUM AZELATE (2:1)DB-254558
Identifiants de bases de données externes
Statistiques de structure avancées
Stéréocentres atomiques définis
0
Stéréocentres atomiques non définis
0
Stéréocentres de liaison définis
0
Stéréocentres de liaison non définis
0
Conformères 3D
0
Identifiants de structure lisibles par machine
SMILES
C(CCCC(=O)[O-])CCCC(=O)[O-].[Na+].[Na+]
InChI
InChI=1S/C9H16O4.2Na/c10-8(11)6-4-2-1-3-5-7-9(12)13;;/h1-7H2,(H,10,11)(H,12,13);;/q;2*+1/p-2
InChIKey
QFYNUCAKHMSPCY-UHFFFAOYSA-L

Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Structure chimique 2D PubChem pour le CAS 52457-54-2
CAS 52457-54-2PubChem CID 162680

Chimie vérifiée pour le CAS 52457-54-2

Azelaic acid, dipotassium salt

Nom IUPAC
dipotassium;nonanedioate
Formule moléculaire
C9H14K2O4
Masse moléculaire
264.40 g/mol
Masse exacte
264.01662189 Da
Masse monoisotopique
264.01662189 Da
Surface polaire topologique
80,3 Ų
Complexité moléculaire
136,0
Charge formelle
0
Donneurs de liaisons hydrogène
0
Accepteurs de liaisons hydrogène
4
Liaisons rotatives
6
Atomes lourds
15
Unités covalentes
3

Noms et synonymes signalés à PubChem

RefChem:589030Dipotassium azelateAzelaic acid, potassium saltDipotassium nonanedioateNonanedioic acid, dipotassium saltNonanedioic acid, potassium salt (1:2)Nonanedioic acid, potassium saltPotassium nonanedioate
5 autres noms signalés
Potassium azelateEINECS 257-931-2UNII-C98170693JEINECS 243-190-2RTMGQVSGXYZVTE-UHFFFAOYSA-L
Identifiants de bases de données externes
Statistiques de structure avancées
Stéréocentres atomiques définis
0
Stéréocentres atomiques non définis
0
Stéréocentres de liaison définis
0
Stéréocentres de liaison non définis
0
Conformères 3D
0
Identifiants de structure lisibles par machine
SMILES
C(CCCC(=O)[O-])CCCC(=O)[O-].[K+].[K+]
InChI
InChI=1S/C9H16O4.2K/c10-8(11)6-4-2-1-3-5-7-9(12)13;;/h1-7H2,(H,10,11)(H,12,13);;/q;2*+1/p-2
InChIKey
RTMGQVSGXYZVTE-UHFFFAOYSA-L

Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Source officielle et provenance

Source enregistrée
Health Canada Cosmetic Ingredient Hotlist
Référence de la source
Hotlist restricted entry 12
Identifiant de la fiche source
restricted:12
Version de la source
Health Canada Hotlist 2025-08-13
Langue de la source
English
État de la traduction
Original is English
Source mise à jour le
2025-08-13
Instantané vérifié le
2026-08-30 04:07 UTC
Méthode de validation
strict HTML tables t1=490 and t2=90
SHA-256
8b52ff573d08373ee90121f6a701b3607e4a3d6fc748a7d56171eb53510af91a

Notes du jeu de données enregistré

Couverture du jeu de données
Administrative prohibitions, restrictions, conditions and warning requirements
Note sur l’autorité
Official Health Canada compliance indicator; not a complete safety clearance

Place de cette fiche dans le jeu de données du marché

580
fiches Canada actuelles
90
fiches marquées Restricted
580
fiches de cette version de la source
516
fiches du marché avec identité CAS

Répartition des statuts

Un texte de conditions est présent pour 172 des 580 fiches actuelles. Un champ de conditions vide est interprété selon le type de fiche ci-dessus ; il n’est jamais converti en une affirmation d’utilisation sans restriction.

Canada contexte du marché

Complete Hotlist snapshot

Version de la couverture : Health Canada Cosmetic Ingredient Hotlist, 13 August 2025

All prohibited and restricted Hotlist entries, including conditions and warning requirements published in the official list.

Liste de contrôle de vérification

  1. Search English/French names and CAS identifiers.
  2. Apply every restriction, concentration and label warning.
  3. Check Food and Drugs Act/Cosmetic Regulations requirements.
  4. Recheck the current Hotlist before notification or sale.

Sources officielles du marché

Procédure de vérification et exhaustivité de la fiche

Avant d’utiliser ce résultat dans une décision de conformité

  1. Confirmez que « Azelaic acid and its salts » et chaque identifiant CAS/CE correspondent à la matière de votre spécification fournisseur.
  2. Search English/French names and CAS identifiers.
  3. Apply every restriction, concentration and label warning.
  4. Check Food and Drugs Act/Cosmetic Regulations requirements.
  5. Recheck the current Hotlist before notification or sale.
  6. Consignez la version de la source et revérifiez auprès de l’autorité de réglementation avant la fabrication, la notification ou la mise sur le marché.

Champs disponibles dans cette fiche

  • Nom officiel de la substanceDisponible
  • CASDisponible
  • ECNon fourni
  • Texte de condition distinctDisponible
  • Date d’effetNon fourni
  • Empreinte de l’instantané et méthodeDisponible

Questions auxquelles cette page répond

This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record. Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.

If this row does not reproduce conditions, open the cited official detail because omission does not mean unrestricted use. The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.

La fiche cite Hotlist restricted entry 12, version de la source Health Canada Hotlist 2025-08-13. Ouvrir la source officielle.

Non. Le CAS aide à déterminer l’identité, mais les juridictions peuvent classer différemment une même substance et appliquer des champs d’application, limites, avertissements et dates de transition différents.

Citation stable

Azelaic acid and its salts. Hotlist restricted entry 12. Canada. Source version Health Canada Hotlist 2025-08-13. CosIng Checker regulatory record: https://cosingchecker.com/fr/regulations/ca/records/502/

Citez l’autorité de réglementation comme autorité juridique. Cette page est un index structuré de preuves et une aide à la vérification, et non un substitut au texte officiel ni à une évaluation juridique professionnelle.

Interprétation et limites pour Canada

This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.

Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.

Comment interpréter le rôle juridique

The authority uses this source as compliance guidance; the underlying legislation remains controlling.

Preuves sur cette page

  • Résultat enregistré : Restricted
  • Rôle juridique : Official guidance
  • Version de la source : Health Canada Hotlist 2025-08-13

Ce que cela ne prouve pas

The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.

Recherche complémentaire sur la substance auprès de sources faisant autorité

Aucune de ces sources ne prévaut sur la décision de marché ci-dessus.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

Rechercher cette identité à la source

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

Rechercher cette identité à la source

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

Rechercher cette identité à la source

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

Rechercher cette identité à la source

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

Rechercher cette identité à la source

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

Rechercher cette identité à la source

US EPA CompTox CTX APIs

Clé d’API requise pour l’import

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

Rechercher cette identité à la source